small ruminants
  • Blog
  • Videos
  • About us
  • Contact us
  • Subscribe
  • English
    • Français
    • Italiano
    • Español
    • Ελληνικα
  • Blog
  • Videos
  • About us
  • Contact us
  • Subscribe
  • English
    • Français
    • Italiano
    • Español
    • Ελληνικα

How can we reduce the use of antibiotics for mastitis?

  • November 2, 2022
Facebook
Twitter
LinkedIn
Antibiotics are often necessary to treat infections, but poor practices can cause the emergence of resistance. Mastitis is a disease that usually requires treatment with antibiotics, but it is possible to reduce their use. How can we do this? The following study evaluated the efficacy of VIMCO®, HIPRA’s ovine-caprine mastitis vaccine, in reducing treatments for mastitis on a goat farm.

Mastitis in goat

Mastitis in goat, mainly caused by Staphylococcus, is a disease that causes great financial losses. A vaccination plan should always be included in the mastitis control program.

vaccinating against mastitis

Studies show that vaccination against mastitis caused by Staphylococcus decreases clinical and subclinical cases, and also reduces the excretion of pathogens.

Study objectives and methods

In this field study, we wanted to evaluate the efficacy of vaccination against Staphylococcus mastitis in reducing treatments for the disease.

The study was carried out on a farm with 550 dairy goats (Murciano-Granadina), with 5 kidding periods per year and with Staphylococcus mastitis problems.

Vaccination with VIMCO® began in August 2014, and the number of treatments before (2 years prior) and after (1 year) immunization were compared. The treatments registered monthly were: antibiotics + anti-inflammatories (A) and anti-inflammatories only (B).

 

What are the results?

The results show that after vaccination with VIMCO®, fewer treatments were necessary, whether antibiotic or anti-inflammatory.

Number of treatments before and after vaccinating against mastitis with VIMCO®.
Fig. 1: Number of treatments before and after vaccinating against mastitis with VIMCO®.

When comparing the data recorded before and after vaccination, we see significant differences in the use of treatments. The reductions in antibiotic use + NSAID, NSAID only and total treatments were 31%, 90% and 52% respectively.

Number of treatments per month before and after vaccination with VIMCO®.
Fig. 2. Number of treatments per month before and after vaccination with VIMCO®.

 

Conclusions

– By vaccinating with VIMCO®, we can reduce mastitis treatments to a great extent.

– This is related to the reduction in clinical cases (both severe and mild).

– Vaccination is key to driving the reduction in use of antibiotics.

 

Article written by: 
Tania Perálvarez Puerta. Global Product Manager, Small Ruminants Franchise – HIPRA

Case of study: evaluation of the impact of mastitis vaccination on mastitis treatment in a dairy goat farm in the southwest of Spain

Previous Post

Understanding Chlamydia abortus: How does the disease present?

Next Post

Colostrum: the first step to ensuring the future of the farm

Related Posts

How can we calculate the profitability of vaccination against abortions?

Key points for the diagnosis of 𝘊. 𝘢𝘣𝘰𝘳𝘵𝘶𝘴: act quickly to effectively control it

October 21, 2025

Transmission of pathogens during milking is the main cause of mastitis in small ruminants. Improper use or malfunction of milking...

Impact Of Vaccination Against Mastitis In Primiparous Goats: A Study In The Netherlands

Beyond health: the economic impact of resistance

September 14, 2025

Transmission of pathogens during milking is the main cause of mastitis in small ruminants. Improper use or malfunction of milking...

CATEGORIES

  • Antibiotic reduction
  • Field experience
  • Footrot
  • Mastitis
  • Other Goats, Sheep and Lamb Diseases
  • Reproductive
  • Respiratory

NEWSLETTER

DON’T MISS ANY UPDATES ON SMALL RUMINANTS

    I have read and agree to the Privacy Policy and Basic information on Data Protection.

    ASK THE EXPERTS

    Your opinion is very important to us, so we encourage you to contact our team of experts on Small Ruminants to ask any questions or discuss any concerns you may have about sheep, goats and lambs health prevention.

      I have read and agree to the Privacy Policy and Basic information on Data Protection.

      Next Post
      Colostrum: the first step to ensuring the future of the farm

      Colostrum: the first step to ensuring the future of the farm

      small ruminants

      Follow us

      Linkedin Youtube
      Categories
      • Antibiotic reduction
      • Field experience
      • Footrot
      • Mastitis
      • Other Goats, Sheep and Lamb Diseases
      • Reproductive
      • Respiratory

      Pages

      • Blog
      • Videos
      • About us
      • Contact

      HIPRA ©2025 All rights reserved

      • Cookie policy
      • Terms of use
      • Privacy policy
      • Cookie policy
      • Terms of use
      • Privacy policy

      Mastitis control program

      Our 6-point mastitis control program is a set of structured measures and practices, validated to improve udder health and milk quality in dairy farms.



        Basic Personal Data Protection information:

        Controller: LABORATORIOS HIPRA, S.A.
        Purposes: Managing the contractual and/or business relationship with HIPRA, including sending news, promotions and invitations to events sponsored by HIPRA.
        Lawful basis: Performance of the contractual relationship and HIPRA's legitimate Interest.
        Recipients: Third parties to which HIPRA has entrusted cloud computing, security, auditing, mailing, technical and computer support services, as well as companies in its group.
        Rights: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our
        Privacy Policy.

        For further information, please check our detailed information on Data Protection.
        close-link
        Powered by Convert Plus

        Basic Personal Data Protection information:

        Controller: LABORATORIOS HIPRA, S.A.
        Purposes: Managing the contractual and/or business relationship with HIPRA, including sending news, promotions and invitations to events sponsored by HIPRA.
        Lawful basis: Performance of the contractual relationship and HIPRA’s legitimate Interest.
        Recipients: Third parties to which HIPRA has entrusted cloud computing, security, auditing, mailing, technical and computer support services, as well as companies in its group.
        Rights: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our Privacy Policy.

        For further information, please check our detailed information on Data Protection.

        Website for veterinarians

        The contents of this website are aimed exclusively at prescribing veterinarians. By clicking on Accept you state that you are a veterinary professional. In other case, please contact a veterinarian and click on Decline.

        ACCEPT
        DECLINE

        NEWSLETTER

        Don´t miss any updates

          I have read and agree to the Privacy Policy and Basic information on Data Protection.

          Informazioni di base sulla protezione dei dati personali:

          Titolare del trattamento: LABORATORIOS HIPRA, S.A.
          Finalità: Gestione del rapporto contrattuale e/o commerciale con HIPRA, incluso l’invio di notizie, promozioni e inviti a eventi sponsorizzati da HIPRA.
          Base giuridica: Esecuzione del rapporto contrattuale e del legittimo interesse di HIPRA.
          Destinatari: Terzi a cui HIPRA ha affidato servizi di cloud computing, sicurezza, auditing, mailing, supporto tecnico e informatico, nonché società del suo gruppo.
          Diritti: Richiedere l'accesso e la rettifica o la cancellazione dei dati personali e altri diritti come spiegato nelle informazioni aggiuntive. Puoi vedere le informazioni aggiuntive dettagliate sulla protezione dei dati nella nostra Informativa sulla privacy.

          Per ulteriori informazioni, puoi consultare le nostre informazioni dettagliate sulla Protezione dei dati.

          Informations de base sur la protection des données personnelles :

          Contrôleur : LABORATORIOS HIPRA, S.A.
          Objectifs : Gérer la relation contractuelle et/ou commerciale avec HIPRA, y compris l'envoi de nouvelles, de promotions et d'invitations à des événements sponsorisés par HIPRA.
          Base légale : Exécution de la relation contractuelle et intérêt légitime d'HIPRA.
          Destinataires : Tiers auxquels HIPRA a confié le cloud computing, la sécurité, l'audit, le mailing, les aspects techniques et informatiques services de support, ainsi que les sociétés de son groupe.
          Droits : demander l'accès et la rectification ou l'effacement des données personnelles et d'autres droits comme expliqué dans les informations supplémentaires. Vous pouvez consulter les informations supplémentaires détaillées sur la protection des données dans notre Politique de confidentialité.

          Pour plus d'informations, veuillez consulter nos informations détaillées sur la protection des données. .

          Βασικές πληροφορίες προστασίας προσωπικών δεδομένων:

          Ελεγκτής: ΕΡΓΑΣΤΗΡΙΟ HIPRA, S.A.
          Σκοποί: Διαχείριση της συμβατικής ή/και επιχειρηματικής σχέσης με την HIPRA, συμπεριλαμβανομένης της αποστολής ειδήσεων, προωθήσεων και προσκλήσεων σε εκδηλώσεις που χρηματοδοτούνται από την HIPRA.
          Νόμιμη βάση: Εκτέλεση της συμβατικής σχέσης και έννομο συμφέρον της HIPRA.
          Παραλήπτες: Τρίτα μέρη στα οποία η HIPRA έχει εμπιστευθεί το cloud computing, την ασφάλεια, τον έλεγχο, την αλληλογραφία, την τεχνική και τον υπολογιστή υπηρεσίες υποστήριξης, καθώς και εταιρείες του ομίλου της.
          Δικαιώματα: Ζητήστε πρόσβαση και διόρθωση ή διαγραφή προσωπικών δεδομένων και άλλων δικαιωμάτων, όπως εξηγείται στις πρόσθετες πληροφορίες. Μπορείτε να δείτε αναλυτικές πρόσθετες πληροφορίες σχετικά με την προστασία δεδομένων στο Πολιτική Απορρήτου.

          Για περισσότερες πληροφορίες, ελέγξτε τις λεπτομερείς πληροφορίες σχετικά με την Προστασία Δεδομένων .

          Información básica sobre protección de datos:

          Responsable del tratamiento: LABORATORIOS HIPRA, S.A.
          Propósitos: Gestionar la relación contractual y comercial con HIPRA, incluido el envío de noticias, promociones e invitaciones a eventos patrocinados por HIPRA.
          Fundamentos legales: Cumplimiento de la relación contractual e interés legítimo de HIPRA.
          Destinatarios: Terceros a los que HIPRA ha encargado las tareas de computación en la nube, seguridad, auditoría, correo, servicios de soporte técnico e informático, así como empresas de su grupo.
          Derechos: Solicitar el acceso y la rectificación o eliminación de los datos personales y otros derechos, tal como se explica en la información adicional. Puede ver la información adicional detallada sobre la protección de datos en nuestra Política de Privacidad.

          Para obtener más información, consulte nuestra información detallada sobre Protección de datos.

          Basic Personal Data Protection information:

          Controller: LABORATORIOS HIPRA, S.A.
          Purposes: Managing the contractual and/or business relationship with HIPRA, including sending news, promotions and invitations to events sponsored by HIPRA.
          Lawful basis: Performance of the contractual relationship and HIPRA's legitimate Interest.
          Recipients: Third parties to which HIPRA has entrusted cloud computing, security, auditing, mailing, technical and computer support services, as well as companies in its group.
          Rights: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our Privacy Policy.

          For further information, please check our detailed information on Data Protection.